An evaluation of PI3K pathway activation on the efficacy of both trastuzumab and lapatinib

被引：1
|
作者：
Hu, X.
Wang, L. P.
Zhang, Q. L.
Zhang, J.
Guo, H. Y.
Sun, S.
Wang, B. Y.
Jia, Z.
Shao, Z. M.
Wang, Z. H.
机构：
[1] Fudan Univ, Ctr Canc, Shanghai 200433, Peoples R China
[2] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
[4] Fudan Univ, Dept Breast Surg, Inst Canc, Shanghai 200433, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.541
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
541
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cryptotanshinione upregulates α-secretase by activation PI3K pathway in cortical neurons
    Mei, Zhengrong
    Situ, Bing
    Tan, Xiangping
    Zheng, Shiming
    Zhang, Fangyan
    Yan, Pengke
    Liu, Peiqing
    BRAIN RESEARCH, 2010, 1348 : 165 - 173
  • [32] Targeting the PI3K pathway in the brain - pharmacokinetics and efficacy of a PI3k inhibitor optimized to cross the blood-brain barrier
    Salphati, Laurent
    Pang, Jodie
    Cheong, Jonathan
    Plise, Emile G.
    Alicke, Bruno
    Ding, Xiao
    Dotson, Jennafer
    Feng, Dingzhou
    Heffron, Tim
    Joachico, Allan
    Lee, Leslie B.
    Ndubaku, Chudi
    Nishimura, Merry
    Nonomiya, Jim
    Olivero, Alan
    Phillips, Heidi
    Sideris, Setve
    Wang, Lan
    Zhang, Xiaolin
    DRUG METABOLISM REVIEWS, 2011, 43 : 183 - 183
  • [33] Targeting the PI3K Pathway in the Brain-Efficacy of a PI3K Inhibitor Optimized to Cross the Blood-Brain Barrier
    Salphati, Laurent
    Heffron, Timothy P.
    Alicke, Bruno
    Nishimura, Merry
    Barck, Kai
    Carano, Richard A.
    Cheong, Jonathan
    Edgar, Kyle A.
    Greve, Joan
    Kharbanda, Samir
    Koeppen, Hartmut
    Lau, Shari
    Lee, Leslie B.
    Pang, Jodie
    Plise, Emile G.
    Pokorny, Jenny L.
    Reslan, Hani Bou
    Sarkaria, Jann N.
    Wallin, Jeffrey J.
    Zhang, Xiaolin
    Gould, Stephen E.
    Olivero, Alan G.
    Phillips, Heidi S.
    CLINICAL CANCER RESEARCH, 2012, 18 (22) : 6239 - 6248
  • [34] Targeting the PI3K pathway in cancer
    Workman, P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S80 - S80
  • [35] Targeting the PI3K pathway in cancer
    Mills, GB
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S4 - S4
  • [36] The PI3K Pathway in Human Disease
    Fruman, David A.
    Chiu, Honyin
    Hopkins, Benjamin D.
    Bagrodia, Shubha
    Cantley, Lewis C.
    Abraham, Robert T.
    CELL, 2017, 170 (04) : 605 - 635
  • [37] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
    Till, Kathleen J.
    Abdullah, Mariah
    Alnassfan, Tahera
    Janet, Gallardo Zapata
    Marks, Thomas
    Coma, Silvia
    Weaver, David T.
    Pachter, Jonathan A.
    Pettitt, Andrew R.
    Slupsky, Joseph R.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [38] PI3K pathway in prostate cancer: All resistant roads lead to PI3K
    Park, Soonbum
    Kim, Young Sik
    Kim, Davis Yeon
    So, Insuk
    Jeon, Ju-Hong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 198 - 206
  • [39] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
    Kathleen J. Till
    Mariah Abdullah
    Tahera Alnassfan
    Gallardo Zapata Janet
    Thomas Marks
    Silvia Coma
    David T. Weaver
    Jonathan A. Pachter
    Andrew R. Pettitt
    Joseph R. Slupsky
    Scientific Reports, 13
  • [40] A MAP for PI3K activation on endosomes
    Alex G. Batrouni
    Jeremy M. Baskin
    Nature Cell Biology, 2020, 22 : 1292 - 1294
12345